Novo Nordisk

Eli Lilly May Have The Best Chance At Keeping The Momentum Going
Seeking Alpha
Wed, 01/30/13 - 04:16 pm
Eli Lilly
Bristol-Myers Squibb
Novo Nordisk
Pfizer
Sanofi
Big Pharma Diabetes Face-Off
The Motley Fool
Sat, 01/19/13 - 11:07 am
Pharma
diabetes
Bristol-Myers Squibb
Astra Zeneca
Novo Nordisk
GlaxoSmithKline
Analysis: Drug industry bets on new blockbusters in 2013
Reuters
Tue, 01/15/13 - 11:37 am
Roche
GlaxoSmithKline
Eli Lilly
Biogen Idec
Gilead Sciences
Novo Nordisk
Japan gives initial OK to Novo's insulin combo, Ryzodeg
Fierce Pharma
Thu, 12/27/12 - 10:32 pm
Japan
Novo Nordisk
Ryzodeg
The Next Wave of Diabetes Dominance
Motley Fool
Wed, 12/12/12 - 08:11 am
diabetes
Bayer
Sanofi
Novo Nordisk
Abbott Labs
Bristol-Myers Squibb
This Top Big Pharma Stock Just Got an Upgrade
Motley Fool
Sat, 12/8/12 - 11:31 am
Novo Nordisk
Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity
Bloomberg
Tue, 12/4/12 - 11:55 am
GSK
GLP-1 agonist
obesity
diabetes
albiglutide
Victoza
Novo Nordisk
Novo Nordisk says new data show Victoza advantage
Reuters
Tue, 11/27/12 - 10:36 am
diabetes
Novo Nordisk
Victoza
Merck
Amylin
Novo Nordisk A/S: Catching The Increasing Diabetes Trend
Seeking Alpha
Tue, 11/20/12 - 11:27 am
diabetes
Novo Nordisk
Bristol-Myers Squibb
Eli Lilly
Sanofi
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Teva
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novo Nordisk
Novartis
Pfizer
Sanofi
Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth
Seeking Alpha
Tue, 11/13/12 - 12:11 pm
diabetes
degludec
liraglutide
Novo Nordisk
Victoza
This Week in Biotech: Part 1
Motley Fool
Sun, 11/11/12 - 09:17 am
Novartis
Novo Nordisk
Corcept Therapeutics
Biomarin
Sequenom
Novo Aims for Tresiba U.S. Approval in First Half of 2013
Bloomberg
Fri, 11/9/12 - 11:07 am
Novo Nordisk
Tresiba
diabetes
degludec
insulin
FDA panel recommends approval of Novo degludec insulin
Reuters
Thu, 11/8/12 - 09:52 pm
FDA
advisory panels
Novo Nordisk
degludec
insulin
Why Investors Are Voting Against Novo Nordisk
Motley Fool
Wed, 11/7/12 - 11:55 am
Novo Nordisk
FDA
advisory panels
Tresiba
insulin
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Sanofi
Novo Nordisk
MannKind
5 Things to Watch This Week in the Health-Care Sector
Motley Fool
Tue, 11/6/12 - 12:28 pm
Novartis
Signifor
Novo Nordisk
Tresiba
Ryzodeg
HCA Holdings
FDA staff highlight heart risk with Novo insulin
Reuters
Tue, 11/6/12 - 10:12 am
Novo Nordisk
FDA
insulin
degludec
Novo hikes forecast on 62% jump in Victoza sales
Fierce Pharma
Wed, 10/31/12 - 11:14 am
Novo Nordisk
guidance
2012's Best Pharmaceutical Stock
Motley Fool
Sun, 10/28/12 - 11:50 am
Novo Nordisk

Pages